Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc (NYSE: HLN) covers the month of December 2025. The report discloses the company's total voting rights and capital structure as of November 30, 2025. Haleon operates as a global leader in consumer health with a portfolio spanning six categories: Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health, and Therapeutic Skin Health and Other.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of share capital and voting rights.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document updates the share count for regulatory notification purposes under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It serves solely to inform shareholders of the denominator required for calculating notifiable interests.
Key Facts for Investor Verification
- Total Issued Shares: 8,952,353,648 ordinary shares of £0.01 each as of November 30, 2025.
- Treasury Shares: 45,882,158 shares held as treasury stock.
- Voting Shares: 8,906,471,490 ordinary shares with voting rights.
- Regulatory Use: The voting share count is the required denominator for determining notification obligations for changes in interest.
- Contact: Notifiable interests should be directed to company.secretary@haleon.com.